Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2013

Zaino RJ, Abendroth C, Yemelyanova A, Oliva E, Lim D, Soslow R, et al. Endocervical involvement in endometrial adenocarcinoma is not prognostically significant and the pathologic assessment of the pattern of involvement is not reproducible. Gynecol Oncol. 2013;128(1):83-87.

Brait M, Maldonado L, Noordhuis MG, Noordhuis M, Begum S, Loyo M, et al. Association of promoter methylation of VGF and PGP9.5 with ovarian cancer progression. PLoS One. 2013;8(9):e70878.

Chaser BE, Renszel KM, A Crowson N, Osmundson A, Shendrik IV, Yob EH, et al. Onycholemmal carcinoma: a morphologic comparison of 6 reported cases. J Am Acad Dermatol. 2013;68(2):290-5.

Brady N, Chuntova P, Bade LK, Schwertfeger KL. The FGF/FGFR axis as a therapeutic target in breast cancer. Expert Rev Endocrinol Metab. 2013;8(4):391-402.

Green DA, Rink M, Hansen J, Cha EK, Robinson B, Tian Z, et al. Accurate preoperative prediction of non-organ-confined bladder urothelial carcinoma at cystectomy. BJU Int. 2013;111(3):404-11.

Zhang Y, Park E, Kim CS, Paik J-. ZNF365 promotes stalled replication forks recovery to maintain genome stability. Cell Cycle. 2013;12(17):2817-28.

Chadburn A. Immunodeficiency-associated lymphoid proliferations (ALPS, HIV, and KSHV/HHV8). Semin Diagn Pathol. 2013;30(2):113-29.

Magro CM, Yang A, Fraga G. Blastic marginal zone lymphoma: a clinical and pathological study of 8 cases and review of the literature. Am J Dermatopathol. 2013;35(3):319-26.

Beninato T, Scognamiglio T, Kleiman DA, Uccelli A, Vaca D, Fahey TJ, et al. Ten percent tall cells confer the aggressive features of the tall cell variant of papillary thyroid carcinoma. Surgery. 2013;154(6):1331-6; discussion 1336.

Iglesias-Ussel M, Marchionni L, Romerio F. Isolation of microarray-quality RNA from primary human cells after intracellular immunostaining and fluorescence-activated cell sorting. J Immunol Methods. 2013;391(1-2):22-30.